Vaccines and rare disease are priority growth areas in the Gulf. The Senior Access Manager, Vaccines & Rare Disease - Gulf leads market access strategy and execution across the UAE, Kuwait, Qatar, Oman and Bahrain, from National Immunization Program (NIP) inclusion and tender value to reimbursement, funding pathways, named-patient programs and managed-entry agreements for rare-disease medicines.
Based in Dubai, the role is the Gulf point of contact for market access, payer engagement and health technology assessment (HTA) and health economics and outcomes research (HEOR), working closely with regional and global Access & Value colleagues and cross-functional partners.
CORE ACCOUNTABILITIES
1. GCC VACCINE ACCESS
- Lead vaccine access strategy and delivery in the UAE, Kuwait and Qatar, including NIP inclusion and expansion, adult and life-course immunization funding, and tender and procurement pathways.
- Develop NIP submissions and tender value dossiers, partnering with commercial, tender and medical colleagues on launch and lifecycle plans.
- Drive access for new and expanding vaccine indications, including private-insurer and employer channels where relevant.
2. GULF RARE-DISEASE ACCESS
- Lead rare-disease access across all five Gulf markets: reimbursement submissions, funding routes, named-patient programs and managed-entry agreements, supported by regional pricing and HEOR expertise.
3. DISTRIBUTOR-LED MARKETS (OMAN AND BAHRAIN)
- Develop and execute vaccine and rare-disease access plans for Oman and Bahrain in partnership with distributors and internal stakeholders, ensuring alignment on pricing.
4. GULF PAYER ENGAGEMENT
- Engage health authorities, procurement bodies and insurers across the GCC on access matters within approved mandates, in coordination with Policy & Public Affairs.
- Maintain the Gulf payer stakeholder map and engagement plan; prepare leadership for key external meetings.
5. HTA AND HEOR
- Translate Gulf HTA, reimbursement and evidence requirements into regional HEOR priorities; support local adaptation of dossiers and economic models and their use in payer discussions.
6. INSIGHT AND PERFORMANCE TRACKING
- Monitor policy, procurement, competitive and funding developments across the GCC and translate insight into access plans.
- Track access milestones, including NIP decisions, tender outcomes, reimbursement decisions and time to funded access.
DECISION RIGHTS
- Shapes and decides vaccine and rare-disease access plans, NIP roadmaps, tender value positions and managed-entry proposals for the Gulf within regional pricing guidance and approved governance; escalates exceptions.
- Represents Pfizer with Gulf health authorities, procurement bodies and insurers on access matters within approved mandates.
- Prioritizes Gulf HTA and HEOR requests with the regional centre of excellence; reviews vaccine and rare-disease value materials before external use.
CAPABILITIES & QUALIFICATIONS
- Bachelor's degree in Pharmacy, Medicine, Public Health, Health Economics or Life Sciences.
- Minimum 8 years of pharmaceutical experience, including at least 3 years in market access, HEOR, health policy or payer-facing roles.
- Demonstrated experience with GCC public-health, procurement or reimbursement systems in at least one of UAE, Kuwait or Qatar.
- Strong health-economics literacy to act as the Gulf point of contact for HTA and HEOR.
- Fluent in English; Arabic preferred.
PREFERRED
- Postgraduate qualification in Health Economics, Public Health or Business.
- Vaccines and NIP experience; rare-disease reimbursement or managed-entry experience.
- Experience with distributor-led markets.
CRITICAL LEADERSHIP BEHAVIORS
Enterprise Leadership
Thinks across markets and functions; makes choices for total regional value.
External Influence
Builds trust with payers and authorities using evidence and integrity.
Strategic Judgment
Balances patient access, affordability, price sustainability and business value.
Capability Builder
Sets standards, coaches colleagues and raises functional depth.
KEY ORGANIZATIONAL RELATIONSHIPS
- Internal: Access & Value Lead - Middle East; regional and global Access & Value, Pricing and HEOR teams; commercial, category and tender teams; Medical, Regulatory, Policy & Public Affairs, Finance, Legal, Compliance and Supply.
- External: GCC health authorities, NIP committees, procurement and tender bodies, insurers, public-health academics and professional societies, and distribution partners.
OPERATING MODEL
Senior individual contributor based in Dubai, with no direct reports. Works directly with stakeholders in the UAE, Kuwait and Qatar, and with distribution partners in Oman and Bahrain, collaborating closely with regional colleagues.
Pfizer Gulf is an equal-opportunity employer, and we are proud of our commitment to creating a diverse and inclusive candidate pool to support and empower our workforce.
We strive to ensure that our people are heard, seen and cared for by creating an environment that fosters inclusion and inspires colleagues to speak up to promote an engaging and inclusive culture where they can thrive.
Our diverse workforce represents the patients we serve and the communities in which we operate.
We look forward to reviewing your application and thank you for your interest.
To learn more about acceptable and prohibited uses of AI during the recruitment process, please review our candidate AI-use guidelines available on Pfizer Careers .
Market Access
Skills Required
- Bachelor's degree in Pharmacy, Medicine, Public Health, Health Economics, or Life Sciences
- Minimum 8 years of pharmaceutical experience
- At least 3 years of experience in market access, HEOR, health policy, or payer-facing roles
- Experience with GCC public-health, procurement, or reimbursement systems in at least one of the UAE, Kuwait, or Qatar
- Strong health-economics literacy and ability to support HTA and HEOR activities
- Fluency in English
- Arabic language proficiency
- Postgraduate qualification in Health Economics, Public Health, or Business
- Experience with vaccines and National Immunization Programs
- Rare-disease reimbursement or managed-entry experience
- Experience with distributor-led markets
Pfizer Compensation & Benefits Highlights
How does Pfizer ensure its pay and bonus plans are competitive?
Pfizer supports competitive pay through a pay-for-performance approach, total rewards programs, financial benefits and governance practices tied to compensation oversight. Employees and external reviewers point to compensation, benefits, bonuses, time off and stock-related rewards as part of Pfizer’s workplace value proposition.
- Pay-for-performance compensation: Pfizer structures its compensation policies and practices so colleagues are rewarded based on the contributions they make to the business. This approach connects pay to performance, impact and business outcomes, while supporting Pfizer’s broader goal of attracting and retaining talent across research, manufacturing, commercial, digital and corporate functions.
- Total rewards beyond base pay: Pfizer’s total rewards approach includes pay, health and wellness programs, financial benefits and career development resources. The company references country-specific health and disability insurance, preventative health resources, retirement funds, company contributions, life insurance and financial planning education. An R&D data privacy steward said, “Pfizer aces at taking care of its people,” pointing to educational assistance and health care subsidy in retirement. On external review sites, employees also describe Pfizer as offering a “great compensation package,” “good pay” and “great benefits” (Glassdoor).
- Bonus, stock and equity-related rewards: Pfizer’s benefits overview includes performance bonuses and an employee stock purchase plan, and external review data includes positive sentiment around stock and equity. On an external review site, one employee said “stock options are great,” while another cited “commission and insurance” as strong parts of the compensation package (Comparably).
- Compensation, benefits and time off in employee reviews: Employees on external review sites frequently connect Pfizer’s compensation with benefits and paid time off. One process engineer described Pfizer as offering “Great benefits and PTO” and a “Great compensation package,” while another reviewer cited “competitive salary and benefits.” Another employee pointed to “salary and time off/vacation” as the best part of the compensation package. (Glassdoor; Indeed; Comparably)
- External signals:
- Pay and benefits ratings: Pfizer has a 4.1 rating for pay and benefits on one external review site. (Indeed)
- Perks, benefits and employee satisfaction: Pfizer has a B+ rating for perks and benefits, with 75% of employees saying they are satisfied with their benefits. (Comparably)
- Employee review themes: Employees on external review sites mention competitive salary, good pay, strong benefits, PTO, insurance, stock options and compensation packages. (Indeed; Glassdoor; Comparably)
Bottom line: Pfizer supports competitive pay and bonus plans through pay-for-performance practices, broad total rewards, performance bonuses, stock-related programs, financial benefits and compensation practices that employees describe as including strong pay, benefits, PTO and equity-related rewards.
Pfizer Insights
What We Do
Our purpose ensures that patients remain at the center of all we do. We live our purpose by sourcing the best science in the world; partnering with others in the healthcare system to improve access to our medicines; using digital technologies to enhance our drug discovery and development, as well as patient outcomes; and leading the conversation to advocate for pro-innovation/pro-patient policies.
Why Work With Us
We are the inventors, the problem solvers, the big thinkers — those who surmount any hurdle to deliver breakthrough medicines to the people who are counting on them the most.
Gallery
Pfizer Offices
Hybrid Workspace
Employees engage in a combination of remote and on-site work.









